Exploring Premenstrual Syndrome Treatments Market: Rising Trends, Opportunities and Challenges Forecast 2030

Global Premenstrual Syndrome Treatments Market Overview:

According to MarkNtel Advisors study the Global Premenstrual Syndrome Treatment Market is estimated to grow at a CAGR of around 3.7% during the forecast period, i.e., 2024-30. The demand for Premenstrual Syndrome (PMS) treatment solutions has been increasing consistently across the globe in recent years. This has been primarily influenced by the adoption of unhealthy lifestyles by a large population of women across the globe, mainly in regions such as North America and Europe. Globally, instances of PMS have been observed specifically across countries that have a high working female population. This is primarily because working women are generally unable to take care of their physical and mental well-being, owing to the time constraints, which have been leading to a hormonal imbalance among them. Consequently, the symptoms of PMS have been mainly observed among working women. Further, PMS often leads to mental issues like anxiety, depression, stress, etc., which reduces the work efficiency of women. Hence, to reduce the effect of PMS on their work schedule, most women opt for PMS treatment solutions, which have been responsible for the market growth & expansion in recent years.

Key Findings of the Study: Premenstrual Syndrome Treatments market

Global Premenstrual Syndrome Treatment Market Driver:

Growing Instances of Premenstrual Dysphoric Disorder (PMDD) Driving Market Growth – Globally, the instances of PMDD emerged as one of the major market drivers, which has been growing significantly, which is in particular due to the growing fitness issues among women. PMDD is the greater extreme shape of premenstrual syndrome, which often results in excessive bodily abnormalities, like belly pain, weight pain, swelling of breasts, and so forth. Also, the predominant aspect besides PMDD is intense hormonal balance, which is frequently related to the genetics of women. Further, consistent stress and other neurological conditions may also affect the hormonal balance among women, leading to PMDD. Henceforth, as the instances of PMDD have been escalating, the demand for treatment solutions has also amplified, which has been driving the market growth. This demand is also expected to grow in the forecast years, as the instance of PMDD would increase further.

Access Free Sample Report - https://www.marknteladvisors.com/query/request-sample/premenstrual-syndrome-treatment-market.html

Scope of the Premenstrual Syndrome Treatments Market Report Segmentation

-By Drug Type

Analgesics- Market Size & Forecast 2019-2030, USD Million
Antidepressants- Market Size & Forecast 2019-2030, USD Million
Oral Contraceptives- Market Size & Forecast 2019-2030, USD Million
Ovarian Suppression Agents- Market Size & Forecast 2019-2030, USD Million
Others (Diuretics, Herbal Supplements, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Type

Prescription- Market Size & Forecast 2019-2030, USD Million
Over-the-Counter (OTC)- Market Size & Forecast 2019-2030, USD Million

-By Distribution Channel

Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
Online Pharmacies- Market Size & Forecast 2019-2030, USD Million)

For more detailed information about the Premenstrual Syndrome Treatments market report, click here – https://www.marknteladvisors.com/research-library/premenstrual-syndrome-treatment-market.html

Geographical analysis:

-By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

North America has been experiencing substantial growth in the Premenstrual Syndrome Treatment Industry in the past few years. This has been primarily attributed to the high cases of mental health conditions like bipolar issues, stress, anxiety, etc. observed among women across the region. The region has one of the maximum ratios of working women population, which has been responsible for the higher cases of mental health issues. Also, some other foremost issues causing the increase in mental fitness conditions in the region include the escalating adoption of unhealthy lifestyles among women. Women in this region have been observed to mostly follow sedentary lifestyles, and have been involved in consuming junk food, along with smoking and alcohol consumption. Hence, a lot of these elements were contributing to the upward thrust in mental health issues, which have been main to hormonal imbalances among women. Therefore, as a result of this, women throughout the region have been largely driving the demand for PMS medication in the past few years.

Global Premenstrual Syndrome Treatment Industry Recent Development:

2022: Lupin received the US Food and Drug Administration approval for the generic oral contraceptive pill Drospirenone.

Current Landscape of Premenstrual Syndrome Treatments Market

The report delineates key market participants and thoroughly assesses their strategic approaches, trends, innovations, and manufacturing infrastructure, enabling a forecast of their market impact over the next five years. The meticulously researched data presented holds the potential to distinguish even nascent market entrants in the long term. Armed with pertinent data and actionable insights, our research report delivers a comprehensive overview of the market, empowering investors and stakeholders to establish a robust presence in the Premenstrual Syndrome Treatments market. The research report profiles major players, including

Customization of Reports Available - https://www.marknteladvisors.com/query/request-customization/premenstrual-syndrome-treatment-market.html

Bayer AG
Pfizer Inc.
Zydus Cadila
Alkem Laboratories Ltd.
Kobayashi Pharmaceutical Co., Ltd.
Haleon Group of Companies
Johnson & Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Asarina Pharma AB
Lupin
Sun Pharmaceutical Industries Ltd.
Intas Pharmaceuticals Ltd. (Accord Healthcare)
Ova Moon
AstraZeneca plc
Others

Related Reports

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India